Differences in cognitive ability and hippocampal volume between Alzheimer's disease, amnestic mild cognitive impairment, and healthy control groups, and their correlation

Neuroscience Letters

Volumn 620, Issue , 2016, Pages 115-120

  Choi, Mi Hyun ^a   Kim, Hyung Sik ^a   Gim, Seon Young ^a   Kim, Woo Ram ^a   Mun, Kyung Ryul ^a   Tack, Gye Rae ^a   Lee, Bongsoo ^b   Choi, Young Chil ^c   Kim, Hyun Jun ^a   Hong, Seung Hwa ^d   Lim, Dae Woon ^e   Chung, Soon Cheol ^a  

^a Konkuk University   (South Korea)

^b Chung Ang University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Chungbuk National University Hospital   (South Korea)

^e Dongguk University   (South Korea)

Author keywords

Alzheimer disease; Amnestic mild cognitive impairment; Boston naming test; Cognitive ability; Hippocampal volume

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BOSTON NAMING TEST; CLINICAL ARTICLE; COGNITIVE ABILITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE REGISTRY; FEASIBILITY STUDY; FEMALE; HIPPOCAMPAL VOLUME; HUMAN; INVESTIGATIVE PROCEDURES; MALE; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM PARAMETERS; PRIORITY JOURNAL; AMNESIA; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; HIPPOCAMPUS; ORGAN SIZE; PATHOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMNESIA; CASE-CONTROL STUDIES; COGNITION; COGNITIVE DYSFUNCTION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; ORGAN SIZE;

EID: 84962173496     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.03.044     Document Type: Article

References (19)

1. Balthazar M.L., Cendes F., Damasceno B.P. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?. Neuropsychology 2008, 22:703-709.
2. Cho M.J., Bae J.N., Suh G.H., Hahm B.J., Kim J.K., Lee D.W., Kang M.H. Validation of Geriatric Depression Scale, Korean Version(GDS) in the assessment of DSM-III-R major depression. J. Korean Neuropsychiatr. Assoc. 1999, 38:48-63.
3. Davatzikos C., Bhatt P., Shaw L.M., Batmanghelich K.N., Trojanowski J.Q. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol. Aging 2011, 32. (2322. e19-2322. e27).
4. Dickerson B.C., Salat D.H., Bates J.F., Atiya M., Killiany R.J., Greve D.N., Dale A.M., Stern C.E., Blacker D., Albert M.S., Sperling R.A. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 2004, 56:27-35.
5. Fleisher A.S., Sun S., Taylor C., Ward C.P., Gamst A.C., Petersen R.C., Jack C.R., Aisen P.S., Thal L.J. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 2008, 70(3):191-199.
6. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J.L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M.C., Whitehouse P., Winblad B. Mild cognitive impairment. Lancet 2006, 367:1262-1270.
7. Green J.D.W., Baddeley A.D., Hodges J.R. Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test. Neuropsychologia 1996, 34(6):537-551.
8. Hampel H., Burger K., Teipel S.J., Bokde A.L.W., Zetterberg H., Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008, 4:38-48.
9. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
10. Karrasch M., Sinervä E., Grönholm P., Rinne J., Laine M. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurol. Scand. 2005, 111:172-179.
11. Lee J.H., Lee K.U., Lee D.Y., Kim K.W., Jhoo J.H., Lee K.H. Development of the Korean version of the consortium to establish a registry for Alzheimer's Disease (CERAD) Assessment Packet(CERAD-K). J. Gerontol. Ser. B-Psychol. Sci. Soc. Sci. 2002, 57:47-532.
12. Lee S.Y., Yoon S.Y., Kim M.J., Rhee H.Y., Ryu C.W., Jahng G.H. Investigation of the correlation between seoul neuropsychological screening battery scores and the gray matter volume after correction of covariates of the age, gender, and genotypes in patients with AD and MCI. J. Korean Soc. Magn. Reson. Med. 2013, 17(4):294-307.
13. Liana G.A., Dinov I.D., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2867-2873.
14. Mouton P.R., Martin L.J., Calhoun M.E., Dal Forno G., Price D.L. Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia. Neurobiol. Aging 1998, 19(5):371-377.
15. Nathalia C.P.M., Marcio L.F.B., Fernando C., Benito P.D. Hippocampal atrophy and verbal episodic memory performance in amnestic mild cognitive impairment and mild Alzheimer's disease. Dement. Neuropsychol. 2008, 2(1):37-41.
16. Peng G.P., Feng Z., He F.P., Chen Z.Q., Liu X.Y., Liu P., Luo B.Y. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease. CNS Neurosci. Ther. 2015, 21(1):15-22.
17. Storandt M., Hill R.D. Very mild senile dementia of the Alzheimer's type II: Psychometric test performance. Arch. Neurol. 1989, 16:383-386.
18. Villain N., Desgranges B., Viader F., Sayette V., F.lorence M., Landeau B., Baron J.C., Eustache F., Chételat G. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J. Neurosci. 2008, 28(24):6174-6181.
19. Westman E., Simmons A., Zhang Y., Muehlboek J.S., Tunnard C., Liu Y., Collins L., Evans A., Mecocci P., Vella B., Tsolaki M., Kloszewsk I., Soininen H., Lovestone S., Spenger C., Wahlund L.O. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage 2011, 54:1178-1187.